Evaluation of new iron chelators for clinical use

Acta Haematologica
J B Porter

Abstract

Evaluation of new chelators for clinical use is limited by the availability of models which will predict the therapeutic safety margin of chelators in iron-overloaded humans such as those with thalassaemia major. Animal models show significant differences with respect to the relative toxicity of different chelators compared with human. These differences can be ascribed to several factors: differences in iron metabolism between different species, human metabolism being significantly more conservative than in rodents or nonhuman primates; differences in drug metabolism between different species which are often difficult to predict from first principles, and difficulties in obtaining iron-overloaded models that are truly representative of transfusional iron overload clinically. These differences have been highlighted by clinical studies on hydroxypyridinone iron chelators such as 1,2-dimethyl-3-hydroxypyridin-4-one (L1, CP20, deferiprone) and 1,2-diethyl-3-hydroxypyridin-4-one (CP94). New tissue culture approaches towards understanding the mechanisms of neutropenia, cytostasis and apoptosis induced by chelators as well as the relative rates of inhibition of non-haem-iron-containing enzymes such as ribonucleotide reductase are pred...Continue Reading

Citations

Dec 1, 2009·Future Medicinal Chemistry·Heather C HatcherSuzy V Torti
Dec 5, 1998·Free Radical Biology & Medicine·J B GaleyO Cantoni
Oct 3, 2003·Expert Opinion on Pharmacotherapy·Adriana CeciDomenico De Mattia
Oct 8, 1998·Biochemical Pharmacology·N ChenoufiG Lescoat
Feb 1, 1997·Pediatric Clinics of North America·O Diav-Citrin, G Koren
Jul 20, 2002·Blood Reviews·L Merson, N Olivier
Nov 13, 2001·British Journal of Haematology·J B Porter
Oct 29, 2000·British Journal of Haematology·T SergejewH P Schnebli
Jan 5, 2002·Environmental and Molecular Mutagenesis·P WhittakerV C Dunkel
Nov 11, 1999·British Journal of Haematology·O ShalevV A Hoffbrand
Apr 20, 1999·Chemical Research in Toxicology·S BergaminiA Iannone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis